vs
Side-by-side financial comparison of Chemours Co (CC) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $1.3B, roughly 1.1× Chemours Co). BeOne Medicines Ltd. runs the higher net margin — 4.4% vs -3.5%, a 8.0% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs -2.1%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $92.0M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs -1.2%).
The Chemours Company is an American chemical company that was founded in July 2015 as a spin-off from DuPont. It has its corporate headquarters in Wilmington, Delaware, United States. Chemours is the manufacturer of Teflon, the brand name of polytetrafluoroethylene (PTFE), known for its anti-stick properties. It also produces titanium dioxide and refrigerant gases.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
CC vs ONC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.5B |
| Net Profit | $-47.0M | $66.5M |
| Gross Margin | 11.7% | 90.5% |
| Operating Margin | — | 12.4% |
| Net Margin | -3.5% | 4.4% |
| Revenue YoY | -2.1% | 32.8% |
| Net Profit YoY | -261.5% | 143.8% |
| EPS (diluted) | $-0.32 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.3B | $1.5B | ||
| Q3 25 | $1.5B | $1.4B | ||
| Q2 25 | $1.6B | $1.3B | ||
| Q1 25 | $1.4B | $1.1B | ||
| Q4 24 | $1.4B | $1.1B | ||
| Q3 24 | $1.5B | $1.0B | ||
| Q2 24 | $1.6B | $929.2M | ||
| Q1 24 | $1.4B | $751.7M |
| Q4 25 | $-47.0M | $66.5M | ||
| Q3 25 | $46.0M | $124.8M | ||
| Q2 25 | $-380.0M | $94.3M | ||
| Q1 25 | $-5.0M | $1.3M | ||
| Q4 24 | $-13.0M | $-151.9M | ||
| Q3 24 | $-32.0M | $-121.3M | ||
| Q2 24 | $60.0M | $-120.4M | ||
| Q1 24 | $54.0M | $-251.2M |
| Q4 25 | 11.7% | 90.5% | ||
| Q3 25 | 15.6% | 86.1% | ||
| Q2 25 | 17.2% | 87.5% | ||
| Q1 25 | 17.3% | 85.2% | ||
| Q4 24 | 19.4% | 85.8% | ||
| Q3 24 | 19.0% | 83.0% | ||
| Q2 24 | 19.8% | 85.1% | ||
| Q1 24 | 20.9% | 83.4% |
| Q4 25 | — | 12.4% | ||
| Q3 25 | 2.5% | 11.5% | ||
| Q2 25 | -15.4% | 6.7% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | -0.1% | -7.0% | ||
| Q3 24 | -2.1% | -12.0% | ||
| Q2 24 | 4.4% | -11.5% | ||
| Q1 24 | 5.1% | -34.8% |
| Q4 25 | -3.5% | 4.4% | ||
| Q3 25 | 3.1% | 8.8% | ||
| Q2 25 | -23.5% | 7.2% | ||
| Q1 25 | -0.4% | 0.1% | ||
| Q4 24 | -1.0% | -13.5% | ||
| Q3 24 | -2.1% | -12.1% | ||
| Q2 24 | 3.9% | -13.0% | ||
| Q1 24 | 4.0% | -33.4% |
| Q4 25 | $-0.32 | $0.05 | ||
| Q3 25 | $0.31 | $0.08 | ||
| Q2 25 | $-2.53 | $0.06 | ||
| Q1 25 | $-0.03 | $0.00 | ||
| Q4 24 | $-0.07 | $-0.10 | ||
| Q3 24 | $-0.22 | $-0.09 | ||
| Q2 24 | $0.39 | $-0.09 | ||
| Q1 24 | $0.36 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $670.0M | $4.5B |
| Total DebtLower is stronger | $4.1B | $836.4M |
| Stockholders' EquityBook value | $250.0M | $4.4B |
| Total Assets | $7.4B | $8.2B |
| Debt / EquityLower = less leverage | 16.40× | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $670.0M | $4.5B | ||
| Q3 25 | $613.0M | $4.0B | ||
| Q2 25 | $502.0M | $2.8B | ||
| Q1 25 | $464.0M | $2.5B | ||
| Q4 24 | $713.0M | $2.6B | ||
| Q3 24 | $596.0M | $2.7B | ||
| Q2 24 | $604.0M | $2.6B | ||
| Q1 24 | $746.0M | $2.8B |
| Q4 25 | $4.1B | $836.4M | ||
| Q3 25 | $4.1B | — | ||
| Q2 25 | $4.1B | — | ||
| Q1 25 | $4.1B | — | ||
| Q4 24 | $4.1B | — | ||
| Q3 24 | $4.0B | — | ||
| Q2 24 | $4.0B | — | ||
| Q1 24 | $4.0B | — |
| Q4 25 | $250.0M | $4.4B | ||
| Q3 25 | $274.0M | $4.1B | ||
| Q2 25 | $228.0M | $3.8B | ||
| Q1 25 | $566.0M | $3.5B | ||
| Q4 24 | $571.0M | $3.3B | ||
| Q3 24 | $643.0M | $3.4B | ||
| Q2 24 | $714.0M | $3.4B | ||
| Q1 24 | $753.0M | $3.4B |
| Q4 25 | $7.4B | $8.2B | ||
| Q3 25 | $7.5B | $7.6B | ||
| Q2 25 | $7.5B | $6.3B | ||
| Q1 25 | $7.4B | $5.8B | ||
| Q4 24 | $7.5B | $5.9B | ||
| Q3 24 | $7.5B | $5.8B | ||
| Q2 24 | $7.2B | $5.7B | ||
| Q1 24 | $8.0B | $5.7B |
| Q4 25 | 16.40× | 0.19× | ||
| Q3 25 | 14.96× | — | ||
| Q2 25 | 17.99× | — | ||
| Q1 25 | 7.18× | — | ||
| Q4 24 | 7.11× | — | ||
| Q3 24 | 6.20× | — | ||
| Q2 24 | 5.53× | — | ||
| Q1 24 | 5.27× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $137.0M | $417.3M |
| Free Cash FlowOCF − Capex | $92.0M | $379.8M |
| FCF MarginFCF / Revenue | 6.9% | 25.4% |
| Capex IntensityCapex / Revenue | 3.4% | 2.5% |
| Cash ConversionOCF / Net Profit | — | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | $51.0M | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $137.0M | $417.3M | ||
| Q3 25 | $146.0M | $402.6M | ||
| Q2 25 | $93.0M | $263.6M | ||
| Q1 25 | $-112.0M | $44.1M | ||
| Q4 24 | $138.0M | $75.2M | ||
| Q3 24 | $139.0M | $188.4M | ||
| Q2 24 | $-620.0M | $-95.6M | ||
| Q1 24 | $-290.0M | $-308.6M |
| Q4 25 | $92.0M | $379.8M | ||
| Q3 25 | $105.0M | $354.5M | ||
| Q2 25 | $50.0M | $219.8M | ||
| Q1 25 | $-196.0M | $-12.3M | ||
| Q4 24 | $29.0M | $-17.3M | ||
| Q3 24 | $63.0M | $54.7M | ||
| Q2 24 | $-693.0M | $-205.5M | ||
| Q1 24 | $-392.0M | $-465.1M |
| Q4 25 | 6.9% | 25.4% | ||
| Q3 25 | 7.0% | 25.1% | ||
| Q2 25 | 3.1% | 16.7% | ||
| Q1 25 | -14.3% | -1.1% | ||
| Q4 24 | 2.1% | -1.5% | ||
| Q3 24 | 4.2% | 5.5% | ||
| Q2 24 | -44.6% | -22.1% | ||
| Q1 24 | -28.8% | -61.9% |
| Q4 25 | 3.4% | 2.5% | ||
| Q3 25 | 2.7% | 3.4% | ||
| Q2 25 | 2.7% | 3.3% | ||
| Q1 25 | 6.1% | 5.0% | ||
| Q4 24 | 8.0% | 8.2% | ||
| Q3 24 | 5.0% | 13.3% | ||
| Q2 24 | 4.7% | 11.8% | ||
| Q1 24 | 7.5% | 20.8% |
| Q4 25 | — | 6.28× | ||
| Q3 25 | 3.17× | 3.22× | ||
| Q2 25 | — | 2.79× | ||
| Q1 25 | — | 34.71× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -10.33× | — | ||
| Q1 24 | -5.37× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CC
| Titanium Technologies | $563.0M | 42% |
| Thermal And Specialized Solutions | $443.0M | 33% |
| Advanced Performance Materials | $312.0M | 23% |
| Other Non-Reportable Segment | $12.0M | 1% |
ONC
Segment breakdown not available.
